flucytosine has been researched along with thiabendazole in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Vollum, DI | 1 |
Holt, RJ | 1 |
De Clercq, D; De Vroey, C; Kakiesse, M; Mazebo, P | 1 |
Bayles, MA | 1 |
Castro, A; Hidalgo, H; Montero-Gei, F; Solano, E | 1 |
Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
2 review(s) available for flucytosine and thiabendazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
8 other study(ies) available for flucytosine and thiabendazole
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Chromomycosis: a review.
Topics: Chromoblastomycosis; Flucytosine; Humans; Lymphedema; Thiabendazole | 1977 |
New antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Chlorobenzenes; Clotrimazole; Flucytosine; Humans; Imidazoles; Mebendazole; Metronidazole; Miconazole; Mycoses; Thiabendazole; Tinidazole | 1975 |
[Treatment of chromomycosis with a combination of 5-fluorocytosine and thiabendazole. Apropos of a Zairian case due to Fonsecaea pedrosoi].
Topics: Aged; Chromoblastomycosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Male; Mitosporic Fungi; Thiabendazole | 1985 |
Letter: 5-Fluorocytosine treated chromomycosis.
Topics: Administration, Oral; Chromoblastomycosis; Cytosine; Flucytosine; Follow-Up Studies; Humans; Thiabendazole | 1974 |
[Chromomycosis. Treatment with a combination of thiabendazole and 5-fluorocytosine, 6-year follow-up].
Topics: Adult; Aged; Agricultural Workers' Diseases; Chromoblastomycosis; Cytosine; Drug Evaluation; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Middle Aged; Recurrence; Thiabendazole | 1983 |